Skip to content

Engaging Medically Complex Veterans in Tele-Rehabilitation Using a Biobehavioral Approach

Engaging Medically Complex Veterans in Tele-Rehabilitation Using a Biobehavioral Approach: A Pilot Study of Feasibly and Acceptability

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04942613
Enrollment
50
Registered
2021-06-28
Start date
2021-10-22
Completion date
2023-09-08
Last updated
2025-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multimorbidity, Physical Deconditioning

Keywords

telerehabilitation, high intensity, biobehavioral, social support, physical activity

Brief summary

The aims of this study are to determine the feasibility and acceptability of a multicomponent telerehabilitation program for medically complex older Veterans and to preliminarily assess participant outcomes (physical activity, physical function, quality of life, loneliness) to the program.

Detailed description

The aims of this study are to determine the feasibility and acceptability of the multicomponent telerehabilitation program and to preliminarily assess participant outcomes. The multicomponent program/intervention consists of 3 core components: 1) high-intensity rehabilitation interventions, 2) biobehavioral interventions, and 3) social support. The delivery of the program is supported by various technologies allowing for synchronous and asynchronous care and monitoring. Synchronous telerehabilitation will occur individually and in virtual groups. Feasibility and acceptability will be assessed by Veteran adherence to program components and validated surveys. Preliminary responsiveness will be assessed primarily by change in 7-day average step count and secondarily by other physical function tests and patient reported outcome measures. Study findings will have immediate clinical impact as they will guide implementation of safe and effective telerehabilitation strategies for medically complex older Veterans who lack access to standard in-person rehabilitation services.

Interventions

Motivational Interviewing Techniques including but not limited to open-ended questions, reflection, affirmations, and summary will be used to build participant rapport, support behavior change (physical activity), and facilitate program engagement.

strengthening, balance, functional activities, stretching, breathing, aerobic endurance exercise

OTHEREducation

Education on general health topics which may include the following: basic nutrition, stress reduction, sleep hygiene

OTHERQualitative Interview

Qualitative interview to explore patient perspectives of the multicomponent telerehabilitation program (physical therapy, biobehavioral interventions, technology, and social support interventions) and how they contribute to program engagement and participation as well as changes in physical activity.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The outcomes assessor will be blinded to group allocation

Intervention model description

Participants will be randomized to 1 of 2 groups: Group1 will receive the intervention first for 12 weeks, and Group2 will receive the waitlist control for 12 weeks. At the end of 12 weeks, Group2 will crossover to the intervention.

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 60 years of age and older * Multiple chronic conditions (Charlson Comorbidity Index 3) * Impaired physical function (\< or = 10 repetitions on 30 second sit to stand test)

Exclusion criteria

* Life expectancy \< 12 months * Acute or progressive neurological disorder (e.g. Amyotrophic Lateral Sclerosis, recent stroke) * Moderate to severe dementia without caregiver assistance (\< 18 on telephone Montreal Cognitive Assessment (MoCA Blind) * Unstable medical condition precluding safe participation in progressive rehabilitation (e.g. unstable angina)

Design outcomes

Primary

MeasureTime frameDescription
Adherence to the Multicomponent Telehealth InterventionProgram end- 12 weeks in Intervention group (Group1); 24 weeks in Waitlist control (Group2)Adherence will be calculated as the proportion of the number of sessions attended out of the number prescribed per protocol (32 sessions)

Secondary

MeasureTime frameDescription
Feasibility of the Multicomponent Telehealth InterventionProgram end- 12 weeks in Intervention group (Group1); 24 weeks in Waitlist control (Group2)Feasibility will be measured through a validated survey: Feasibility of Intervention Measure consists of 4 items rated on a 5-point Likert scale (1) completely disagree to (5) completely agree. The average of the 4 items are reported. Higher scores indicate greater feasibility of the program.
Acceptability of the Multicomponent Telehealth InterventionProgram end- 12 weeks in Intervention group (Group1); 24 weeks in Waitlist control (Group2)Acceptability will be measured through a validated survey: Acceptability of Intervention Measure consists of 4 items rated on a 5-point Likert scale (1) completely disagree to (5) completely agree. The average of the 4 items are reported. Higher scores indicate greater acceptability of the program.
Participant RecruitmentBaselineRecruitment will be tracked as part of feasibility and to inform a future trial. Recruitment will be reported as a proportion of those enrolled out of the total number screened via phone screen.
Satisfaction of the Multicomponent Telehealth InterventionProgram end- 12 weeks in Intervention group (Group1); 24 weeks in Waitlist control (Group2)Participation satisfaction with care provided via telerehabilitation will be assessed via the VA's approved survey: V-signals. It consists of 11 items rated on a 5-point Likert scale from (1) strongly disagree to (5) strongly agree). The average of the 11 items are reported. Higher scores indicate better satisfaction.
Safety Event CountProgram end- 12 weeks in Intervention group (Group1); 24 weeks in Waitlist control (Group2)The Safety Event Count is the cumulative number of study related (possibly, probably, or definitely) adverse events and severe adverse events counted from baseline to program end. Events will be categorized by type
Exercise Stages of Change QuestionnaireChange from Baseline to 12 weeksFour-item questionnaire used to determine an individual's stage of change (pre-contemplation, contemplation, preparation, action, or maintenance)
Self-efficacy for Exercise (SEE) ScaleChange from Baseline to 12 weeksNine item questionnaire used to measure an individual's self-efficacy for exercising under different conditions. Each item is rated on a scale of 0 (not confident) to 10 (confident). The average of the 9 items is calculated; higher scores indicate better self-efficacy. The change from baseline to 12 weeks is calculated as 12 weeks minus baseline; thus, positive change scores indicate improvement in self-efficacy.
Physical ActivityChange from pre-program (baseline for Group 1, 12 weeks for Group 2) to post-program (12 weeks for Group 1, 24 weeks for Group 2).Physical activity will be measured via accelerometry and will include average 7-day step count
Arm Curl TestChange from Baseline to 12 weeksThis is a functional performance test for upper body strength and is performed on each arm (one arm at a time). It requires the participant to perform as many arm curls (biceps curls) as possible in 30 seconds. Males use an 8lb weight and females use a 5lb weight. Scores are continuous, and higher scores indicate greater arm strength (better outcome)
2-minute Step TestChange from Baseline to 12 weeksThis is a functional performance test for aerobic endurance. It requires participants to march in place for 2 minutes (alternating legs), and the score is the number of repetitions completed on the right leg. Scores are continuous, and higher scores indicate better aerobic endurance.
Activity Measure for Post-Acute Care (AM-PAC) Basic Mobility Outpatient Routine Short FormChange from Baseline to 12 weeksThis questionnaire consists of 18 items rated on a 4-point Likert scale from 1 (unable) to 4 (none) to address the prompt: How much difficulty do you currently have. The total score is reported by summing each item; scores can range from 18 to 72. Higher scores indicate better mobility and less impairment/disability.
3-Item Loneliness ScaleChange from Baseline to 12 weeksThis scale has three items and a simplified set of response categories that is designed to measure overall loneliness. Score range: 3-9. Higher scores indicate higher loneliness.
PROMIS-29+2 Profile v2.1 Physical Health and Mental Health Subscales OnlyChange from Baseline to 12 weeksThis is a patient reported outcome measure to assess physical health (subscale) and mental health (subscale). It is a 29-item questionnaire, and most items are rated on a 5-point Likert scale. There is 1 pain intensity item rated on a 0 (no pain) to 10 (worst pain imaginable) scale. PROMIS scores were transformed to a T-score where 50 represents the population mean, and the standard deviation is 10. The method reported by Hays et al. in 2018 was used to calculate the physical health and mental health subscales. Higher scores for subscales listed indicate better physical and mental health.
Participant Retention12 Weeks and 24 WeeksParticipant retention will be tracked as part of feasibility and to inform a future trial. Retention will be reported as a proportion of the total number of participants who complete all outcome measure timepoints out of the total who complete baseline measures.
30 Second Sit to StandChange from Baseline to 12 weeksThe test uses a standard height chair and requires the participant to stand up and sit down as many times as possible in 30 seconds. More completions indicate better physical function.

Countries

United States

Participant flow

Participants by arm

ArmCount
Multicomponent Telehealth Intervention (Group1)
This group will be randomized to receive the 12-week multicomponent intervention first. They will receive individual physical therapy sessions, group physical therapy sessions, and biobehavioral interventions emphasizing program engagement and increased daily physical activity. Most interventions will be provided synchronously through videoconferencing. Each participant will receive an individualized home exercise program. Motivational Interviewing Techniques: Motivational Interviewing Techniques including but not limited to open-ended questions, reflection, affirmations, and summary will be used to build participant rapport, support behavior change (physical activity), and facilitate program engagement. Physical Therapy Interventions: strengthening, balance, functional activities, stretching, breathing, aerobic endurance exercise
25
Education (Group2)
This group will be randomized to 12-week waitlist control condition. They will receive a one-hour education session every 2 weeks (6 sessions total) on general health topics (e.g., basic nutrition, stress reduction, sleep hygiene). At the end of 12 weeks, they will transition to the 12-week multicomponent intervention Education: Education on general health topics which may include the following: basic nutrition, stress reduction, sleep hygiene
25
Total50

Baseline characteristics

CharacteristicMulticomponent Telehealth Intervention (Group1)TotalEducation (Group2)
Age, Continuous68.4 years
STANDARD_DEVIATION 6
69.2 years
STANDARD_DEVIATION 6.7
69.9 years
STANDARD_DEVIATION 7.3
Berkman Social Disengagement Scale (disengaged)10 Participants20 Participants10 Participants
BMI30.9 kg/m^2
STANDARD_DEVIATION 6.6
31.0 kg/m^2
STANDARD_DEVIATION 6
31.0 kg/m^2
STANDARD_DEVIATION 5.4
Education
Associates Degree or Some College
12 Participants20 Participants8 Participants
Education
Bachelors Degree
5 Participants12 Participants7 Participants
Education
High School or Equivalent
2 Participants3 Participants1 Participants
Education
Post-baccalaureate
6 Participants15 Participants9 Participants
Employment
Retired
20 Participants40 Participants20 Participants
Employment
Unemployed or other
2 Participants5 Participants3 Participants
Employment
Working (full- or part-time)
3 Participants5 Participants2 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
24 Participants46 Participants22 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants3 Participants3 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants1 Participants0 Participants
Functional Comorbidity Index6.0 units on a scale
STANDARD_DEVIATION 1.7
6.0 units on a scale
STANDARD_DEVIATION 1.9
5.9 units on a scale
STANDARD_DEVIATION 2.1
Functional Comorbidity Index Top 6 Diagnoses
Anxiety (Includes PTSD)
13 Participants27 Participants14 Participants
Functional Comorbidity Index Top 6 Diagnoses
Arthritis
16 Participants33 Participants17 Participants
Functional Comorbidity Index Top 6 Diagnoses
Degenerative Disc Disease
16 Participants28 Participants12 Participants
Functional Comorbidity Index Top 6 Diagnoses
Depression
18 Participants29 Participants11 Participants
Functional Comorbidity Index Top 6 Diagnoses
Obesity (BMI > 30 kg/m2
15 Participants31 Participants16 Participants
Functional Comorbidity Index Top 6 Diagnoses
Visual Impairment
15 Participants29 Participants14 Participants
Generalized Anxiety Disorder (GAD) positive for anxiety4 Participants7 Participants3 Participants
Marital Status
Cohabitating
0 Participants1 Participants1 Participants
Marital Status
Divorced or Separated
5 Participants8 Participants3 Participants
Marital Status
Married
14 Participants31 Participants17 Participants
Marital Status
Single
5 Participants7 Participants2 Participants
Marital Status
Widowed
1 Participants3 Participants2 Participants
Military Branch
Air Force
7 Participants12 Participants5 Participants
Military Branch
Army
10 Participants23 Participants13 Participants
Military Branch
Marines
1 Participants5 Participants4 Participants
Military Branch
Navy
7 Participants10 Participants3 Participants
Mobile Device Proficiency Questionnaire (MDPQ-16)67.9 units on a scale
STANDARD_DEVIATION 13.6
68.5 units on a scale
STANDARD_DEVIATION 11.8
69.2 units on a scale
STANDARD_DEVIATION 9.9
Number of Rural Participants1 Participants7 Participants6 Participants
Patient Health Questionnaire (PHQ-9) positive for depression7 Participants14 Participants7 Participants
Polypharmacy (≥ 5 meds)24 Participants48 Participants24 Participants
Prescription Medications (total)14.1 number of prescriptions
STANDARD_DEVIATION 7.9
12.9 number of prescriptions
STANDARD_DEVIATION 6.8
11.6 number of prescriptions
STANDARD_DEVIATION 5.3
Race (NIH/OMB)
American Indian or Alaska Native
3 Participants3 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
4 Participants5 Participants1 Participants
Race (NIH/OMB)
More than one race
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
17 Participants41 Participants24 Participants
Sex: Female, Male
Female
9 Participants18 Participants9 Participants
Sex: Female, Male
Male
16 Participants32 Participants16 Participants
Support at Home
All the time
11 Participants26 Participants15 Participants
Support at Home
No
6 Participants10 Participants4 Participants
Support at Home
Some or Most of the Time
8 Participants14 Participants6 Participants
Telephone Montreal Cognitive Assessment (cognitive impairment)6 Participants16 Participants10 Participants
Top 3 Frequent Medications
Antidepressant
12 Participants21 Participants9 Participants
Top 3 Frequent Medications
Beta Blocker
7 Participants15 Participants8 Participants
Top 3 Frequent Medications
Diuretic
6 Participants16 Participants10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 250 / 251 / 250 / 25
other
Total, other adverse events
6 / 254 / 2512 / 2516 / 25
serious
Total, serious adverse events
0 / 250 / 250 / 250 / 25

Outcome results

Primary

Adherence to the Multicomponent Telehealth Intervention

Adherence will be calculated as the proportion of the number of sessions attended out of the number prescribed per protocol (32 sessions)

Time frame: Program end- 12 weeks in Intervention group (Group1); 24 weeks in Waitlist control (Group2)

Population: All participants; data from both groups will be pooled for analysis.

ArmMeasureValue (MEDIAN)
All ParticipantsAdherence to the Multicomponent Telehealth Intervention0.95 Proportion of sessions attended
Secondary

2-minute Step Test

This is a functional performance test for aerobic endurance. It requires participants to march in place for 2 minutes (alternating legs), and the score is the number of repetitions completed on the right leg. Scores are continuous, and higher scores indicate better aerobic endurance.

Time frame: Change from Baseline to 12 weeks

Population: All participants completing the 12 week testing. Group 1 had 1 withdrawal and 1 participant unable to complete all outcome measures due to new medical diagnosis.

ArmMeasureValue (MEDIAN)
All Participants2-minute Step Test15.0 number of repetitions
Education (Group2)2-minute Step Test0.0 number of repetitions
Secondary

30 Second Sit to Stand

The test uses a standard height chair and requires the participant to stand up and sit down as many times as possible in 30 seconds. More completions indicate better physical function.

Time frame: Change from Baseline to 12 weeks

Population: All participants completing the 12 week testing. Group 1 had 1 withdrawal and 1 participant unable to complete all outcome measures due to new medical diagnosis.

ArmMeasureValue (MEDIAN)
All Participants30 Second Sit to Stand1.0 Number of sit to stand repetitions
Education (Group2)30 Second Sit to Stand1.0 Number of sit to stand repetitions
Secondary

3-Item Loneliness Scale

This scale has three items and a simplified set of response categories that is designed to measure overall loneliness. Score range: 3-9. Higher scores indicate higher loneliness.

Time frame: Change from Baseline to 12 weeks

Population: All participants completing the 12 week testing. Group 1 had 1 withdrawal and 1 participant unable to complete all outcome measures due to new medical diagnosis.

ArmMeasureValue (MEDIAN)
All Participants3-Item Loneliness Scale0.0 units on a scale
Education (Group2)3-Item Loneliness Scale0.0 units on a scale
Secondary

Acceptability of the Multicomponent Telehealth Intervention

Acceptability will be measured through a validated survey: Acceptability of Intervention Measure consists of 4 items rated on a 5-point Likert scale (1) completely disagree to (5) completely agree. The average of the 4 items are reported. Higher scores indicate greater acceptability of the program.

Time frame: Program end- 12 weeks in Intervention group (Group1); 24 weeks in Waitlist control (Group2)

Population: All participants with complete data; data from both groups will be pooled for analysis.

ArmMeasureValue (MEDIAN)
All ParticipantsAcceptability of the Multicomponent Telehealth Intervention5.0 score on a scale
Secondary

Activity Measure for Post-Acute Care (AM-PAC) Basic Mobility Outpatient Routine Short Form

This questionnaire consists of 18 items rated on a 4-point Likert scale from 1 (unable) to 4 (none) to address the prompt: How much difficulty do you currently have. The total score is reported by summing each item; scores can range from 18 to 72. Higher scores indicate better mobility and less impairment/disability.

Time frame: Change from Baseline to 12 weeks

Population: All participants completing the 12 week testing. Group 1 had 1 withdrawal and 1 participant unable to complete all outcome measures due to new medical diagnosis.

ArmMeasureValue (MEDIAN)
All ParticipantsActivity Measure for Post-Acute Care (AM-PAC) Basic Mobility Outpatient Routine Short Form4.0 units on a scale
Education (Group2)Activity Measure for Post-Acute Care (AM-PAC) Basic Mobility Outpatient Routine Short Form1.6 units on a scale
Secondary

Arm Curl Test

This is a functional performance test for upper body strength and is performed on each arm (one arm at a time). It requires the participant to perform as many arm curls (biceps curls) as possible in 30 seconds. Males use an 8lb weight and females use a 5lb weight. Scores are continuous, and higher scores indicate greater arm strength (better outcome)

Time frame: Change from Baseline to 12 weeks

Population: All participants completing the 12 week testing. Group 1 had 1 withdrawal and 1 participant unable to complete all outcome measures due to new medical diagnosis. Group 2 had 1 participant not complete this outcome measure.

ArmMeasureGroupValue (MEDIAN)
All ParticipantsArm Curl TestDominant3.0 Number of arm curl repetitions
All ParticipantsArm Curl TestNon-dominant3.0 Number of arm curl repetitions
Education (Group2)Arm Curl TestDominant0.5 Number of arm curl repetitions
Education (Group2)Arm Curl TestNon-dominant1 Number of arm curl repetitions
Secondary

Exercise Stages of Change Questionnaire

Four-item questionnaire used to determine an individual's stage of change (pre-contemplation, contemplation, preparation, action, or maintenance)

Time frame: Change from Baseline to 12 weeks

Population: All Participants

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
All ParticipantsExercise Stages of Change QuestionnaireAction1 Participants
All ParticipantsExercise Stages of Change QuestionnaireContemplation8 Participants
All ParticipantsExercise Stages of Change QuestionnaireMaintenance4 Participants
All ParticipantsExercise Stages of Change QuestionnairePreparation12 Participants
All ParticipantsExercise Stages of Change QuestionnairePre-contemplation0 Participants
Education (Group2)Exercise Stages of Change QuestionnairePreparation3 Participants
Education (Group2)Exercise Stages of Change QuestionnaireAction8 Participants
Education (Group2)Exercise Stages of Change QuestionnaireMaintenance10 Participants
Education (Group2)Exercise Stages of Change QuestionnaireContemplation3 Participants
Education (Group2)Exercise Stages of Change QuestionnairePre-contemplation0 Participants
Education (Group2) BaselineExercise Stages of Change QuestionnairePreparation6 Participants
Education (Group2) BaselineExercise Stages of Change QuestionnairePre-contemplation1 Participants
Education (Group2) BaselineExercise Stages of Change QuestionnaireContemplation12 Participants
Education (Group2) BaselineExercise Stages of Change QuestionnaireAction2 Participants
Education (Group2) BaselineExercise Stages of Change QuestionnaireMaintenance4 Participants
Education (Group 2) 12 WeeksExercise Stages of Change QuestionnaireAction2 Participants
Education (Group 2) 12 WeeksExercise Stages of Change QuestionnaireContemplation11 Participants
Education (Group 2) 12 WeeksExercise Stages of Change QuestionnairePre-contemplation1 Participants
Education (Group 2) 12 WeeksExercise Stages of Change QuestionnairePreparation6 Participants
Education (Group 2) 12 WeeksExercise Stages of Change QuestionnaireMaintenance5 Participants
Secondary

Feasibility of the Multicomponent Telehealth Intervention

Feasibility will be measured through a validated survey: Feasibility of Intervention Measure consists of 4 items rated on a 5-point Likert scale (1) completely disagree to (5) completely agree. The average of the 4 items are reported. Higher scores indicate greater feasibility of the program.

Time frame: Program end- 12 weeks in Intervention group (Group1); 24 weeks in Waitlist control (Group2)

Population: All participants with complete data; data from both groups will be pooled for analysis.

ArmMeasureValue (MEDIAN)
All ParticipantsFeasibility of the Multicomponent Telehealth Intervention5.0 units on a scale
Secondary

Participant Recruitment

Recruitment will be tracked as part of feasibility and to inform a future trial. Recruitment will be reported as a proportion of those enrolled out of the total number screened via phone screen.

Time frame: Baseline

Population: Number phone screened

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
All ParticipantsParticipant Recruitment50 Participants
Secondary

Participant Retention

Participant retention will be tracked as part of feasibility and to inform a future trial. Retention will be reported as a proportion of the total number of participants who complete all outcome measure timepoints out of the total who complete baseline measures.

Time frame: 12 Weeks and 24 Weeks

Population: Total number of participants. The investigators considered retention to be study retention in addition to intervention retention, which included the outcome assessments at all time points. Thus, even though participants in Group 1 did not receive any intervention from weeks 12-24, they were still considered enrolled in the study until their 24 week outcome assessment was completed, they withdrew, or were lost to follow-up.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
All ParticipantsParticipant Retention12 Week Retention24 Participants
All ParticipantsParticipant Retention24 Week Retention20 Participants
Education (Group2)Participant Retention12 Week Retention25 Participants
Education (Group2)Participant Retention24 Week Retention22 Participants
Secondary

Physical Activity

Physical activity will be measured via accelerometry and will include average 7-day step count

Time frame: Change from pre-program (baseline for Group 1, 12 weeks for Group 2) to post-program (12 weeks for Group 1, 24 weeks for Group 2).

Population: All participants with complete step count data will be analyzed. Since only pre-program and post-program data were collected, the data were pooled to increase statistical power.

ArmMeasureValue (MEDIAN)
All ParticipantsPhysical Activity-95 steps
Secondary

PROMIS-29+2 Profile v2.1 Physical Health and Mental Health Subscales Only

This is a patient reported outcome measure to assess physical health (subscale) and mental health (subscale). It is a 29-item questionnaire, and most items are rated on a 5-point Likert scale. There is 1 pain intensity item rated on a 0 (no pain) to 10 (worst pain imaginable) scale. PROMIS scores were transformed to a T-score where 50 represents the population mean, and the standard deviation is 10. The method reported by Hays et al. in 2018 was used to calculate the physical health and mental health subscales. Higher scores for subscales listed indicate better physical and mental health.

Time frame: Change from Baseline to 12 weeks

Population: All participants completing the 12 week testing. Group 1 had 1 withdrawal and 1 participant unable to complete all outcome measures due to new medical diagnosis.

ArmMeasureGroupValue (MEDIAN)
All ParticipantsPROMIS-29+2 Profile v2.1 Physical Health and Mental Health Subscales OnlyPhysical Health2.1 score on a scale
All ParticipantsPROMIS-29+2 Profile v2.1 Physical Health and Mental Health Subscales OnlyMental Health0.3 score on a scale
Education (Group2)PROMIS-29+2 Profile v2.1 Physical Health and Mental Health Subscales OnlyPhysical Health-0.3 score on a scale
Education (Group2)PROMIS-29+2 Profile v2.1 Physical Health and Mental Health Subscales OnlyMental Health-2.1 score on a scale
Secondary

Safety Event Count

The Safety Event Count is the cumulative number of study related (possibly, probably, or definitely) adverse events and severe adverse events counted from baseline to program end. Events will be categorized by type

Time frame: Program end- 12 weeks in Intervention group (Group1); 24 weeks in Waitlist control (Group2)

Population: Number of adverse events

ArmMeasureGroupValue (NUMBER)
All ParticipantsSafety Event CountFalls2 number of adverse events
All ParticipantsSafety Event CountED Visit3 number of adverse events
All ParticipantsSafety Event CountHospitalization1 number of adverse events
All ParticipantsSafety Event CountOther1 number of adverse events
All ParticipantsSafety Event CountUnrelated Falls13 number of adverse events
All ParticipantsSafety Event CountUnrelated ED Visits7 number of adverse events
All ParticipantsSafety Event CountUnrelated Hospitalizations4 number of adverse events
All ParticipantsSafety Event CountUnrelated Other4 number of adverse events
Education (Group2)Safety Event CountUnrelated Other10 number of adverse events
Education (Group2)Safety Event CountFalls1 number of adverse events
Education (Group2)Safety Event CountUnrelated Falls19 number of adverse events
Education (Group2)Safety Event CountED Visit1 number of adverse events
Education (Group2)Safety Event CountUnrelated Hospitalizations2 number of adverse events
Education (Group2)Safety Event CountHospitalization0 number of adverse events
Education (Group2)Safety Event CountUnrelated ED Visits10 number of adverse events
Education (Group2)Safety Event CountOther3 number of adverse events
Secondary

Satisfaction of the Multicomponent Telehealth Intervention

Participation satisfaction with care provided via telerehabilitation will be assessed via the VA's approved survey: V-signals. It consists of 11 items rated on a 5-point Likert scale from (1) strongly disagree to (5) strongly agree). The average of the 11 items are reported. Higher scores indicate better satisfaction.

Time frame: Program end- 12 weeks in Intervention group (Group1); 24 weeks in Waitlist control (Group2)

Population: All participants with complete data; data from both groups will be pooled for analysis.

ArmMeasureValue (MEDIAN)
All ParticipantsSatisfaction of the Multicomponent Telehealth Intervention4.9 score on a scale
Secondary

Self-efficacy for Exercise (SEE) Scale

Nine item questionnaire used to measure an individual's self-efficacy for exercising under different conditions. Each item is rated on a scale of 0 (not confident) to 10 (confident). The average of the 9 items is calculated; higher scores indicate better self-efficacy. The change from baseline to 12 weeks is calculated as 12 weeks minus baseline; thus, positive change scores indicate improvement in self-efficacy.

Time frame: Change from Baseline to 12 weeks

Population: All participants completing the 12 week testing. Group 1 had 1 withdrawal and 1 participant unable to complete all outcome measures due to new medical diagnosis.

ArmMeasureValue (MEDIAN)
All ParticipantsSelf-efficacy for Exercise (SEE) Scale0.0 score on a scale
Education (Group2)Self-efficacy for Exercise (SEE) Scale0.0 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026